This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2022.
Company Filing History:
1 out of 17 
1 out of 264 
Years Active: 2022
Title: Yong Yea Park: Innovator in Cancer Treatment
Introduction
Yong Yea Park is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
One of his key patents is titled "Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same." This invention focuses on an anti-MSLN antibody that exhibits high affinity and specificity for MSLN, making it a promising candidate for effective cancer prevention and treatment.
Career Highlights
Yong Yea Park has worked with esteemed organizations such as the Mogam Institute for Biomedical Research and the Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Yang Mi Lim and Ki Su Kim. Their collaborative efforts have further enhanced the impact of his work in the field of biomedical research.
Conclusion
Yong Yea Park's innovative work in developing anti-MSLN antibodies represents a significant advancement in cancer treatment. His contributions continue to inspire future research in this critical area of medicine.